publication date: Jul 22, 2011
This issue is free and open to the public.
- A Year at NCI: Harold Varmus Reflects on Provocative Questions, the Duke Scandal, Financial Disaster and Grant Review
- Part one of a two-part interview with NCI Director Harold Varmus
- Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication
- ODAC Votes for Accelerated Approval for Adcetris for Two Lymphoma Indications
- Richard Pazdur's Comments to ODAC
- Department of Defense offering $16 million in Cancer Research Grants